Satsuma Pharmaceuticals Inc (STSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 0 | 464,820 | 458,931 | 421,523 | 420,992 |
| Operating Expenses | 4,947 | 0 | 0 | 0 | 0 |
| Operating Income | -4,947 | N/A | N/A | N/A | N/A |
| Interest Expense | 15 | 54,787 | 84,522 | 109,097 | 161,106 |
| Other Income | -210 | 186,295 | 178,200 | 148,230 | -63,176 |
| Pre-tax Income | -5,172 | 131,508 | 93,678 | 39,133 | -224,282 |
| Income Tax | N/A | 37,867 | -292,043 | 0 | 0 |
| Net Income Continuous | -5,172 | 93,641 | 385,721 | 39,133 | -224,282 |
| Net Income | $-5,172 | $93,641 | $385,721 | $39,133 | $-224,282 |
| EPS Basic Total Ops | -9.26 | 1.50 | 6.21 | 0.63 | -53.05 |
| EPS Basic Continuous Ops | -9.25 | 1.50 | 6.21 | 0.63 | -15.73 |
| EPS Diluted Total Ops | -9.26 | 1.48 | 6.14 | 0.63 | -53.05 |
| EPS Diluted Continuous Ops | -9.25 | 1.48 | 6.14 | 0.63 | -15.73 |
| EBITDA(a) | $-4,922 | $N/A | $N/A | $N/A | $N/A |